Inventor · disambiguated record
Kenneth Rhodes
Also filed as: RHODES KENNETH · RHODES KENNETH J
21 granted patents·13 pending applications·45 citations·filing 1999–2025
92Inventor score
Files withWYETH CORP7JANSSEN PHARMACEUTICA NV5MILLENNIUM PHARM INC4YUMANITY THERAPEUTICS INC4LEONARD KRISTI A3
Top patents by PatentIndex Score
34 records- 0192US12275723B2Compounds and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2023·Granted Apr 15, 2025·1 cites·16 claims
- 0291US10973810B2Methods for the treatment of neurological disordersYUMANITY THERAPEUTICS INC·Filed 2018·Granted Apr 13, 2021·7 cites·10 claims
- 0390US8894999B2Use of DR6 and p75 antagonists to promote survival of cells of the nervous systemBIOGEN IDEC INC·Filed 2013·Granted Nov 25, 2014·10 cites·14 claims
- 0487US8501178B2Use of DR6 and p75 antagonists to promote survival of cells of the nervous systemMI SHA·Filed 2009·Granted Aug 6, 2013·7 cites·18 claims
- 0586US12433880B2Methods for the treatment of neurological disordersJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Oct 7, 2025·1 cites·23 claims
- 0679US11873298B2Compounds and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2018·Granted Jan 16, 2024·1 cites·8 claims
- 0779US7803793B2Heterocyclic derived metalloprotease inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Sep 28, 2010·5 cites·32 claims
- 0877US2025304569A1Compounds and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2025·Application pending·0 cites
- 0963US11241417B2Compositions and methods for the treatment and prevention of neurological disordersYUMANITY THERAPEUTICS INC·Filed 2019·Granted Feb 8, 2022·0 cites·8 claims
- 1063US8883473B2Methods of treatment using allosteric processing inhibitors for matrix metalloproteinasesLEONARD KRISTI A·Filed 2012·Granted Nov 11, 2014·1 cites·14 claims
- 1163US2022110920A1Compositions and methods for the treatment and prevention of neurological disordersYUMANITY THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1259US2015203585A1Use of DR6 and p75 Antagonists to Promote Survival of Cells of the Nervous SystemBIOGEN IDEC INC·Filed 2014·Application pending·0 cites
- 1357US7041795B2Potassium channel interacting polypeptides and uses thereofWYETH CORP·Filed 2002·Granted May 9, 2006·0 cites·13 claims
- 1456US7049094B2Methods for identifying modulators of N-type ion channel inactivationWYETH CORP·Filed 2002·Granted May 23, 2006·1 cites·4 claims
- 1553US2024016810A1Compositions and methods for the treatment and prevention of neurological disordersKINETA INC·Filed 2021·Application pending·0 cites
- 1651US7556938B1Nucleic acids encoding potassium channel interactorsMILLENNIUM PHARM INC·Filed 2000·Granted Jul 7, 2009·0 cites·18 claims
- 1751US7439029B2Human 9q polypeptides methodWYETH CORP·Filed 2002·Granted Oct 21, 2008·0 cites·5 claims
- 1851US7078481B1Potassium channel interactors and uses thereforMILLENNIUM PHARM INC·Filed 2000·Granted Jul 18, 2006·0 cites·22 claims
- 1950US8798939B2Methods for designing, selecting and/or optimizing allosteric processing inhibitors for matrix metalloproteinasesLEONARD KRISTI A·Filed 2012·Granted Aug 5, 2014·0 cites·4 claims
- 2047US2020222400A1Methods for the treatment of neurological disordersYUMANITY THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2146US7049083B2Methods for identifying modulators of N-type ion channel inactivationWYETH CORP·Filed 2002·Granted May 23, 2006·0 cites·18 claims
- 2245US2008085893A1Matrix metalloprotease inhibitorsYANG SHYH-MING·Filed 2007·Application pending·0 cites
- 2345US2003024001A1Knock in transgenic mammal containing a non-functional N-terminus of Kv beta 1.1 subunitWYETH CORP·Filed 2002·Application pending·0 cites
- 2445US2016115540A1Prodrugs and drugsBIOGEN MA INC·Filed 2014·Application pending·0 cites
- 2544US2006148000A1Methods for identifying modulators of N-type ion channel inactivationWYETH CORP·Filed 2006·Application pending·0 cites
- 2640US6369197B1Potassium channel interactors and uses thereforMILLENNIUM PHARM INC·Filed 1999·Granted Apr 9, 2002·2 cites·12 claims
- 2740US6361971B1Nucleic acid molecules encoding potassium channel interactors and uses thereforMILLENNIUM PHARM INC·Filed 1999·Granted Mar 26, 2002·6 cites·13 claims
- 2838US8753857B2Crystal structure of the pro form of a matrix metalloproteinase and an allosteric processing inhibitorLEONARD KRISTI A·Filed 2012·Granted Jun 17, 2014·0 cites·4 claims
- 2938US2012302573A1Methods of inhibiting pro matrix metalloproteinase activationJACKSON PAUL FRANCIS·Filed 2012·Application pending·0 cites
- 3037US2015315267A1A method of reducing brain amyloid plaques using anti-ab antibodiesBUSSIERE THIERRY·Filed 2013·Application pending·0 cites
- 3136US6689581B1Potassium channel interactors and uses thereforWYETH CORP·Filed 1999·Granted Feb 10, 2004·1 cites·53 claims
- 3234US2010279986A1Heterocyclic derived metalloprotease inhibitorsZHANG YUE-MEI·Filed 2010·Application pending·0 cites
- 3327US2002019020A1Methods for treating cardiovascular disordersFiled 1999·Application pending·0 cites
- 3423US7115381B1Methods for treating cardiovascular disordersRHODES KENNETH·Filed 1999·Granted Oct 3, 2006·2 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Kenneth Rhodes files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →